Y. Ishii

发表

Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation.

M. Dietrich, T. Horvath, S. Bouret, 2012, Cell metabolism.

Necklace cytoplasmic bodies in hereditary myopathy with early respiratory failure

J. Kira, I. Nonaka, Y. Hayashi, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Relationship between fatty liver disease and intracranial main artery stenosis.

K. Hirata, Keisuke Suzuki, H. Takekawa, 2014, Internal medicine.

Phase I study of AG-120, an IDH1 mutant enzyme inhibitor: Results from the cholangiocarcinoma dose escalation and expansion cohorts.

E. Maher, A. Zhu, G. Abou-Alfa, 2017 .

Interferon ɣ (IFN-ɣ) gene signature and tryptophan 2,3-dioxygenase 2 (TDO2) gene expression: a potential predictive composite biomarker for linrodostat mesylate (BMS-986205; indoleamine 2,3-dioxygenase 1 inhibitor [IDO1i]) + nivolumab (NIVO)

D. Greenawalt, L. Siu, J. Luke, 2019, Annals of Oncology.

Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy

S. Okabe, T. Tauchi, K. Ohyashiki, 2007, International journal of hematology.

Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.

K. Ohyashiki, H. Hsiao, G. Sashida, 2006, Cancer genetics and cytogenetics.

Hypereosinophilia in a Patient with Invasive Thymoma with Clonal T-Lymphocyte Expansion Expressing CD4, CD8, and CD25 Antigens

H. Kato, Y. Suga, T. Ohira, 2006, International journal of hematology.

[Selective muscular atrophy in a family with hereditary myopathy with early respiratory failure].

K. Hirata, I. Nishino, N. Kokubun, 2020, Rinsho shinkeigaku = Clinical neurology.

Clinical significance of trace quantities of tumor cells detected by real-time RT-PCR in bone marrow from patients with esophageal cancer

Y. Kajiyama, I. Nagaoka, M. Tsurumaru, 2009 .

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

Satoru Miyano, Rui Yamaguchi, Seiichiro Yamamoto, 2012, Cancer research.

Copy number alteration analysis for neuroblastoma using droplet digital polymerase chain reaction

T. Morio, J. Takita, M. Takagi, 2021, Pediatrics international : official journal of the Japan Pediatric Society.

Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes.

Koichi Goto, Yutaka Nishiwaki, Seiichiro Yamamoto, 2010, Carcinogenesis.

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial

P. Catalano, C. Horak, G. Freeman, 2019, Clinical Cancer Research.

CheckMate 214 post-hoc analyses of nivolumab plus ipilimumab or sunitinib in IMDC intermediate/poor-risk patients with previously untreated advanced renal cell carcinoma with sarcomatoid features.

R. Motzer, T. Powles, T. Choueiri, 2019, Journal of Clinical Oncology.

Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma.

E. V. Van Allen, Catherine J. Wu, T. Choueiri, 2019, JAMA oncology.

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

A. Ravaud, S. Signoretti, R. Motzer, 2020, Clinical Cancer Research.

Association of human endogenous retrovirus (hERV) expression with clinical efficacy of PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).

P. Catalano, C. Horak, G. Freeman, 2019, Journal of Clinical Oncology.

Granulocyte colony-stimulating factor (G-CSF) could enhance Fcγ receptor expression in neutrophils of patients with B-cell lymphoma treated with rituximab

A. Gotoh, K. Ohyashiki, G. Sashida, 2005, Leukemia & lymphoma.

Successful treatment with imatinib mesylate of hypereosinophilic syndrome (chronic eosinophilic leukemia) with myelofibrosis.

T. Tauchi, K. Ohyashiki, Yoshikazu Ito, 2004, Leukemia research.

Acceleration time ratio for the assessment of extracranial internal carotid artery stenosis

Hideaki Tanaka, K. Hirata, E. Takada, 2013, Journal of Medical Ultrasonics.

A Japanese case of autoimmune autonomic ganglionopathy (AAG) and a review of AAG cases in Japan

M. Hayashi, Y. Ishii, 2009, Autonomic Neuroscience.

L1CAM Is a Marker for Enriching Corticospinal Motor Neurons in the Developing Brain

J. Takahashi, Y. Ono, Bumpei Samata, 2020, Frontiers in Cellular Neuroscience.

Embryonic birthdate of hypothalamic leptin-activated neurons in mice.

S. Bouret, Y. Ishii, 2012, Endocrinology.

A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.

M. Meng, Sam S. Chang, J. Gschwend, 2019, Journal of Clinical Oncology.

BMS-986205, an indoleamine 2,3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (NIVO): Updated safety across all tumor cohorts and efficacy in pts with advanced bladder cancer (advBC).

J. Desai, K. Gelmon, G. Curigliano, 2018 .

ACTR-46. AG-120, A FIRST-IN-class MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: UPDATED RESULTS FROM THE PHASE 1 NON-ENHANCING GLIOMA POPULATION

Raymond Y Huang, E. Maher, P. Wen, 2017 .

A phase 2, randomized study of nivolumab or nivolumab plus BMS-986205 with or without intravesical bacillus Calmette-Guerin in patients with bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer: CheckMate 9UT

M. Meng, Sam S. Chang, J. Witjes, 2019, European Urology Supplements.

Williams–Beuren Syndrome as a Potential Risk Factor for Burkitt Lymphoma

M. Hagiwara, T. Awaya, Ryo Kimura, 2018, Front. Genet..

Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma

A. Bello, Joshua Zhang, Rui Wang, 2019, Journal of Immunotherapy for Cancer.

Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype

L. Gillberg, B. Meister, Y. Ishii, 2006, The European journal of neuroscience.

EXTH-34. COMBINED USE OF THE PAN-IDH MUTANT INHIBITOR AG-881 WITH RADIATION THERAPY SHOWS ADDED BENEFIT IN AN ORTHOTOPIC IDH1 MUTANT GLIOMA MODEL IN VIVO

Brandon Nicolay, J. Murtie, E. Aguado, 2017 .

Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells

T. Morio, M. Takagi, M. Masutani, 2023, Scientific reports.

Serum insulin‐like growth factor‐1 levels in neurodegenerative diseases

K. Hirata, Keisuke Suzuki, H. Fujita, 2019, Acta Neurologica Scandinavica.

BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC).

J. Desai, K. Gelmon, F. D. De Braud, 2019, Journal of Clinical Oncology.

Cryptic chromosomal anomaly in a patient with acute myeloid leukemia leading to AML1/ETO fusion with unfavorable prognostic factors.

K. Ohyashiki, G. Sashida, T. Takaku, 2005, Cancer genetics and cytogenetics.

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

S. Miyano, K. Kumamoto, J. Yokota, 2012, Cancer research.